Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001193125-21-076206
Filing Date
2021-03-10
Accepted
2021-03-10 16:07:36
Documents
6

Document Format Files

Seq Description Document Type Size
1 F-1/A d19910df1a.htm F-1/A 68269
2 EX-10.7 d19910dex107.htm EX-10.7 688741
3 GRAPHIC g19910dsp10.jpg GRAPHIC 7687
4 GRAPHIC g19910dsp11.jpg GRAPHIC 3698
5 GRAPHIC g19910g0201212702325.jpg GRAPHIC 5044
6 GRAPHIC g19910st4.jpg GRAPHIC 3121
  Complete submission text file 0001193125-21-076206.txt   785680
Mailing Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD STEVENAGE X0 SG1 2FX
Business Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD STEVENAGE X0 SG1 2FX 44 (0) 1438 906855
Achilles Therapeutics plc (Filer) CIK: 0001830749 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-253735 | Film No.: 21729745
SIC: 2836 Biological Products, (No Diagnostic Substances)